Favorable long-term outcomes seen with treat-to-target strategy in early rheumatoid arthritis

For patients with aboriginal rheumatoid arthritis (RA) managed with a treat-to-target strategy, accomplishment of sustained remission astatine 2 years is associated with higher remission rates and amended carnal relation astatine 10 years, according to a survey published online Oct. 15 successful Annals of the Rheumatic Diseases.